tobramycin has been researched along with Helicobacter Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geraedts, AA; Tytgat, GN; van der Ende, A; van der Hulst, RW; van der Voort, PH; Zandstra, DF | 1 |
| Geraedts, AA; Kesecioglu, J; Tytgat, GN; van der Ende, A; van der Hulst, RW; van der Voort, PH; Zandstra, DF | 1 |
1 trial(s) available for tobramycin and Helicobacter Infections
| Article | Year |
|---|---|
Gut decontamination of critically ill patients reduces Helicobacter pylori acquisition by intensive care nurses.
Topics: Adult; Amphotericin B; Breath Tests; Colistin; Critical Care; Critical Illness; Cross Infection; Cross-Sectional Studies; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Nursing Staff, Hospital; Prevalence; Stomach Diseases; Tobramycin | 2001 |
1 other study(ies) available for tobramycin and Helicobacter Infections
| Article | Year |
|---|---|
In vitro susceptibility of Helicobacter pylori to, and in vivo suppression by, antimicrobials used in selective decontamination of the digestive tract.
Topics: Administration, Topical; Amphotericin B; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Decontamination; Digestive System; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Polymyxins; Tobramycin | 2000 |